Latest / Stock Movers / Abivax Soars, Siemens Energy Up, Mowi's Net Loss
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Well, let's take a look at some of the stocks
- 0:17Speaker 3: on the move today in Europe. I'm to you at
- 0:20Speaker 3: Adibay with Stephen Carroll, and we're joined by Bloomberg reporter
- 0:23Speaker 3: Chloe Melly. Chloe, good morning. It looks like global equities
- 0:27Speaker 3: are on track for their best quarter in almost six years.
- 0:30Speaker 3: So let's see who's benefiting. It seems like Abbivax maybe
- 0:34Speaker 3: one of the winners.
- 0:35Speaker 4: Yes, absolutely, we've seen chez really soaring this morning for Abbivax,
- 0:39Speaker 4: and that is because this is a biotech company. It
- 0:41Speaker 4: came out with some positive clinical trial results and crucially
- 0:45Speaker 4: those results also eased some concerns that cancer could have
- 0:49Speaker 4: been a potential side effect of its most promising experimental drugs.
- 0:53Speaker 4: So this is an experimental drug that is used to
- 0:56Speaker 4: treat inflammatory bowel disease and in a clitical trial early
- 1:00Speaker 4: this month, Abbyvesk's had disclosed that there had been cases
- 1:03Speaker 4: of tumors among some patients, and of course, when that
- 1:06Speaker 4: was disclosed, shares really plunged because there were some worries
- 1:10Speaker 4: that this might impede that regulatory approval process. But then
- 1:14Speaker 4: today Abivec said that those tumors occurred in patients who
- 1:18Speaker 4: were at risk already of developing cancer and in some
- 1:21Speaker 4: cases had a prior history of having skin cancer. So
- 1:24Speaker 4: that's essentially to say that the drug and the cases
- 1:26Speaker 4: were unrelated, and Liss are saying that this should really
- 1:29Speaker 4: put to rest any concerns around those cancer cases, and
- 1:33Speaker 4: also that the results really confirmed how promising, how effective
- 1:37Speaker 4: at this drug is, and so this might also revive
- 1:40Speaker 4: some of that m and a conversation that had been
- 1:42Speaker 4: circulating around abby vacs before those results came out, because
- 1:47Speaker 4: it could be potentially a prime takeover target for some
- 1:50Speaker 4: big pharmaceutical companies.
- 1:52Speaker 1: Okay, so that's on abbivax. Now, interesting to see when
- 1:57Speaker 1: we're thinking about the tech trade and the huge eye
- 2:00Speaker 1: that we've seen in shares in that area. Of course,
- 2:02Speaker 1: youwer tech companies listed in Europe, but Seemen's energy is
- 2:04Speaker 1: part of that story that we're following this morning. Yeah.
- 2:07Speaker 4: Absolutely, it's very interesting because we've seen obviously this tech
- 2:11Speaker 4: rally on Wall Street spilling over into Asia and then
- 2:14Speaker 4: now spilling over into Europe, but obviously it's a bit
- 2:17Speaker 4: of a different shape in Europe because it doesn't have
- 2:20Speaker 4: as many big tech companies and so investor exposure to
- 2:24Speaker 4: AI to tech is gained in other ways. And so
- 2:26Speaker 4: Siemen's Energy is one of those companies that is really
- 2:29Speaker 4: benefiting from that because it provides gas turbines that are
- 2:34Speaker 4: used to power data centers and it recently raises it
- 2:37Speaker 4: outlook because it's order backlog for those guest turbines is
- 2:40Speaker 4: massive and it has so much demand. There's other European
- 2:44Speaker 4: names that provide some of that sort of infrastructure framework
- 2:48Speaker 4: around AI, and really are companies that partner up with
- 2:51Speaker 4: those hyperscalers, So companies like Schneider Electric or abb or Prismian,
- 2:56Speaker 4: all of those companies that are big beneficiaries of the
- 2:59Speaker 4: AI boo without really being AI companies themselves. And of
- 3:04Speaker 4: course investors do have to do that for Europe because
- 3:06Speaker 4: the way to the tech sector in the stock six
- 3:08Speaker 4: hundred is just nine percent compared to forty four percent
- 3:12Speaker 4: for the S and P five hundred, to this huge
- 3:14Speaker 4: gap there and investor appetite for AI has to be
- 3:17Speaker 4: satisfied in some way and Semens energy is up about
- 3:21Speaker 4: thirty seven percent a year today, but it might have
- 3:24Speaker 4: even further to go if that AI rarey continues.
- 3:27Speaker 3: Okay, from Semens to seafood. Now looks like the company
- 3:30Speaker 3: Maui are looking at net losses this morning. What's going
- 3:34Speaker 3: on there?
- 3:34Speaker 4: Yeah, so Maui is actually the world's largest company in
- 3:37Speaker 4: salmon and trout farming, so big player in that space,
- 3:39Speaker 4: and down this morning quite a lot after selling part
- 3:43Speaker 4: of its farming operations in Canada, which means that it'll
- 3:46Speaker 4: have to take a write down of about one hundred
- 3:48Speaker 4: and forty million Canadian dollars and then also cutting its
- 3:51Speaker 4: harvest forecast. So this salmon farming industry is exposed to
- 3:56Speaker 4: a lot of challenges. There has been tariff and certainty.
- 3:59Speaker 4: There's been also a lot of oversupply, which means that
- 4:01Speaker 4: salmon prices have come down. There's also always this environmental
- 4:05Speaker 4: risks like a sea lice or a climate change disruption
- 4:09Speaker 4: that means that a team seat temperatures are going up.
- 4:11Speaker 4: And then there's also in addition to that, new carbon
- 4:14Speaker 4: regulations that means a potential increase in costs going forward.
- 4:18Speaker 4: So as we can see from this list, of challenges
- 4:21Speaker 4: that I've just given is not a very easy sector
- 4:23Speaker 4: to operate in, and that might explain that twenty five
- 4:26Speaker 4: percent drop in the sheares for MAUI this year and
- 4:29Speaker 4: the further weakness that we saw today as well.
- 4:32Speaker 2: The Stock Movers report from Bloomberg Radio. Check back with
- 4:36Speaker 2: us throughout the day for the latest roundup of companies
- 4:39Speaker 2: making news on Wall Street and for the latest market
- 4:42Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:47Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:50Speaker 2: the Bloomberg Business app.